Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 15 descriptions
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Ambrisentan (Volibris) | 1件: Ambrisentan Ambrisentan (Volibris) | 1件: Ambrisentan
Ambrisentan
(Volibris) 💬1. Ambrisentan
| 1件: EDNRA EDNRA 💬1. Ambrisentan
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | 7件: 51 51, 84, 85, 86, 88, 210, 211 💬
| ||||||||||||||
2 | Ambrisentan - high dose (Volibris) | 1件: Ambrisentan Ambrisentan (Volibris) | 1件: Ambrisentan
Ambrisentan
(Volibris) 💬2. Ambrisentan - high dose
| 1件: EDNRA EDNRA 💬2. Ambrisentan - high dose
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | 1件: 86 86 💬2. Ambrisentan - high dose
| ||||||||||||||
3 | Ambrisentan - low dose (Volibris) | 1件: Ambrisentan Ambrisentan (Volibris) | 1件: Ambrisentan
Ambrisentan
(Volibris) 💬3. Ambrisentan - low dose
| 1件: EDNRA EDNRA 💬3. Ambrisentan - low dose
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | 1件: 86 86 💬3. Ambrisentan - low dose
| ||||||||||||||
4 | Ambrisentan 5 mg (Volibris) | 1件: Ambrisentan Ambrisentan (Volibris) | 1件: Ambrisentan
Ambrisentan
(Volibris) 💬4. Ambrisentan 5 mg
| 1件: EDNRA EDNRA 💬4. Ambrisentan 5 mg
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | 1件: 88 88 💬4. Ambrisentan 5 mg
| ||||||||||||||
5 | Ambrisentan 5 mg film-coated tablets (Volibris) | 1件: Ambrisentan Ambrisentan (Volibris) | 1件: Ambrisentan
Ambrisentan
(Volibris) 💬5. Ambrisentan 5 mg film-coated tablets
| 1件: EDNRA EDNRA 💬5. Ambrisentan 5 mg film-coated tablets
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | 1件: 86 86 💬5. Ambrisentan 5 mg film-coated tablets
| ||||||||||||||
6 | Ambrisentan 5mg film-coated tablets [marketed product] (Volibris) | 1件: Ambrisentan Ambrisentan (Volibris) | 1件: Ambrisentan
Ambrisentan
(Volibris) 💬6. Ambrisentan 5mg film-coated tablets [marketed product]
| 1件: EDNRA EDNRA 💬6. Ambrisentan 5mg film-coated tablets [marketed product]
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | 1件: 86 86 💬6. Ambrisentan 5mg film-coated tablets [marketed product]
| ||||||||||||||
7 | Ambrisentan plus Spironolactone (Volibris) | 2件: Ambrisentan Ambrisentan (Volibris),Spironolactone | 2件: Spironolactone
Spironolactone
,Ambrisentan (Volibris) 💬 7. Ambrisentan plus Spironolactone
| 2件: EDNRA EDNRA,NR3C2 💬 | 8件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-recepto ... | 1件: 86 86 💬7. Ambrisentan plus Spironolactone
| ||||||||||||||
8 | Ambrisentan Tablet (Volibris) | 1件: Ambrisentan Ambrisentan (Volibris) | 1件: Ambrisentan
Ambrisentan
(Volibris) 💬8. Ambrisentan Tablet
| 1件: EDNRA EDNRA 💬8. Ambrisentan Tablet
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | 1件: 86 86 💬8. Ambrisentan Tablet
| ||||||||||||||
9 | Bosentan, Ambrisentan (Volibris) | 2件: Ambrisentan Ambrisentan (Volibris),Bosentan | 3件: Bosentan
Bosentan
,Ambrisentan (Volibris), Bosentan 💬 9. Bosentan, Ambrisentan
| 2件: EDNRA EDNRA,EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in c ... | 1件: 86 86 💬9. Bosentan, Ambrisentan
| ||||||||||||||
10 | Tadalafil and ambrisentan upfront combination therapy (Volibris) | 2件: Ambrisentan Ambrisentan (Volibris),Tadalafil | 2件: Tadalafil
Tadalafil
,Ambrisentan (Volibris) 💬 10. Tadalafil and ambrisentan upfront combination therapy
| 2件: EDNRA EDNRA,PDE5A 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways ... | 2件: 51 51, 86 💬
|